Management of Preoperative Anaemia in Surgical Oncology
Status:
Recruiting
Trial end date:
2024-08-13
Target enrollment:
Participant gender:
Summary
Preoperative anemia is detrimental in surgical patients, and its treatment with transfusions
can further worsen outcomes, including increased hospital stay and mortality. Transfusions
are also highly costly. In 2010, the World Health Organization endorsed the adoption of
Patient Blood Management (PBM) programs, i.e., patient-centered multidisciplinary activities,
including recognition and treatment of preoperative anemia. While the latter has been proved
effective in reducing transfusions in setting like elective orthopedic surgery, widespread
adoption is still lacking. Moreover, little is known about surgical oncology, a particular
setting posing unique challenging. This change-promoting project attempts to fill this
knowledge gap by establishing a multidisciplinary team aimed at optimal management of
preoperative anemia in hepatobiliary/pancreas/gastrointestinal/renal surgical oncology. The
primary endpoint is the reduction of transfusions, along with safer patient outcomes as
compared to the historical series.